NPPA and familial dilated cardiomyopathy: Natriuretic peptides (NPs), such as natriuretic peptide type A (atrial natriuretic peptide-ANP) and natriuretic peptide type B (brain natriuretic peptide-BNP), have been suggested as potential biomarkers for DCM in previous studies [33,72].